|
Volumn 2014, Issue , 2014, Pages 632307-
|
Anti-VEGF for the management of diabetic macular edema
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AFLIBERCEPT;
APTAMER;
BEVACIZUMAB;
HYBRID PROTEIN;
MONOCLONAL ANTIBODY;
PEGAPTANIB;
RANIBIZUMAB;
VASCULOTROPIN A;
VASCULOTROPIN RECEPTOR;
VEGFA PROTEIN, HUMAN;
ANTAGONISTS AND INHIBITORS;
CLINICAL TRIAL (TOPIC);
COMPLICATION;
DIABETIC RETINOPATHY;
GENE EXPRESSION;
GENETICS;
HUMAN;
IMMUNOLOGY;
INTRAVITREAL DRUG ADMINISTRATION;
LASER COAGULATION;
MACULAR EDEMA;
PATHOLOGY;
ANTIBODIES, MONOCLONAL, HUMANIZED;
APTAMERS, NUCLEOTIDE;
CLINICAL TRIALS AS TOPIC;
DIABETIC RETINOPATHY;
GENE EXPRESSION;
HUMANS;
INTRAVITREAL INJECTIONS;
LIGHT COAGULATION;
MACULAR EDEMA;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
RECOMBINANT FUSION PROTEINS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 84912126569
PISSN: None
EISSN: 23147156
Source Type: Journal
DOI: 10.1155/2014/632307 Document Type: Review |
Times cited : (60)
|
References (0)
|